RK
Raj Kantilal Patel
About Raj Kantilal Patel
Data last updated:
Raj Kantilal Patel has 12 years in corporate governance. Holds Designated Partner role. Currently with 2 companies, including Pyrol Energy Llp and Elixherb Pharmaceutical Llp. Formerly with 3 companies, such as Medhaavan Educare Llp and Patel Petro Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 18 Apr 2017 | 2017 | – | Active | |
| Designated Partner | 17 Mar 2016 | 2016 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 12 May 2017 | 2017 | – | Strike Off | |
| Director | 25 Jul 2014 | 1988 | ₹50.05 Cr (FY 2025) | Active | |
| Designated Partner | 10 Aug 2020 | 2020 | – | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raj Kantilal Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raj Kantilal Patel
Raj Kantilal Patel has 12 years in corporate governance. Holds Designated Partner role. Currently with 2 companies, including Pyrol Energy Llp and Elixherb Pharmaceutical Llp. Formerly with 3 companies, such as Medhaavan Educare Llp and Patel Petro Private Limited. Engaged in General Business. Contributes to corporate operations.
Raj Kantilal Patel is associated with 2 companies as Designated Partner, including Elixherb Pharmaceutical Llp, Pyrol Energy Llp.
Raj Kantilal Patel has expertise in General Business.
Raj Kantilal Patel has 12 years in corporate governance.
Raj Kantilal Patel currently holds positions at 2 companies: Elixherb Pharmaceutical Llp, Pyrol Energy Llp.